Effects of one month treatment with propranolol and metoprolol on the relaxant and contractile function of isolated trachea from rats exposed to cigarette smoke for four months

References

• Andreas S, Anker SD, Scanlon PD, et al. (2005). Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 128:3618–24
   PubMed Web of Science ®Google Scholar
• Au DH, Bryson CL, Fan VS, et al. (2004). Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with COPD. Am J Med 117:925–31
   PubMed Web of Science ®Google Scholar
• Barnett MJ, Milavetz G, Kaboli PJ. (2005). Beta-blocker therapy in veterans with asthma or COPD. Pharmacotherapy 25:1550–9
   PubMed Web of Science ®Google Scholar
• Bristow MR. (2000). β-Adrenergic receptor blockade in chronic heart failure. Circulation 101:558–69
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. (2007). Guidelines for the diagnosis and management of chronic heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 35:1076–95
   PubMedGoogle Scholar
• Cosio M, Ghezzo H, Hogg JC, et al. (1978). The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 298:1277–81
   PubMed Web of Science ®Google Scholar
• Craig T, Richerson HB, Moeckli J. (1996). Problem drugs for the patient with asthma. Compr Ther 22:339–44
   PubMedGoogle Scholar
• Davis BB, Shen YH, Tancredi DJ, et al. (2012). Leukocytes are recruited through the bronchial circulation to the lung in a spontaneously hypertensive rat model of COPD. PLoS One 7:33304
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Rowe SM, Johnson JE, et al. (2008). Use of beta-blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 63:301–5
   PubMed Web of Science ®Google Scholar
• Dunnill M.S. (1962). Quantitative methods in the study of pulmonary pathology. Thorax 17:320–8
   PubMedGoogle Scholar
• Gilmartin GS, Lynch M, Tamisier R, et al. (2010). Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol 299:925–31
   Web of Science ®Google Scholar
• JNC VI. (1997). The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 157:2413–46
   PubMedGoogle Scholar
• Kendall GJ. (1997). Clinical relevance of pharmacokinetic differences between beta-blockers. Am J Cardiol 80:15–19
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A, Rengo G, Funakoshi H, et al. (2007). Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med 13:315–23
   PubMed Web of Science ®Google Scholar
• Mario Cazzola, Mathieu Molimard. (2010). The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD. Pulm Pharma Therap 23:257–67
   PubMed Web of Science ®Google Scholar
• Nguyen LP, Omoluabi O, Parra S, et al. (2008). Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol 38:256–62
   PubMed Web of Science ®Google Scholar
• Nguyen LP, Lin R, Parra S, et al. (2009). Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci USA 106:2435–40
   PubMed Web of Science ®Google Scholar
• Raupach T, Bahr F, Herrmann P, et al. (2008). Slow breathing reduces sympathoexcitation in COPD. Eur Respir J 32:387–92
   PubMed Web of Science ®Google Scholar
• Rengo G, Lymperopoulos A, Zincarelli C, et al. (2012). Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α2-adrenoceptor–catecholamine production axis in heart failure. Br J Pharmacol 166:2430–40
   PubMed Web of Science ®Google Scholar
• Rutten FH, Zuithoff NP, Hak E, et al. (2010). Beta-blockers may reduce mortality and risk of exacerbations in patients with COPD. Arch Intern Med 170:880–7
   PubMed Web of Science ®Google Scholar
• Shelton RJ, Rigby AS, Cleland JG, et al. (2006). Effect of a community heart failure clinic on uptake of beta-blockers by patients with obstructive airways disease and heart failure. Heart 92:33l–6
   Web of Science ®Google Scholar
• Shen N, He B. (2011). Anticholinergics may play more roles in COPD. Chin Med J 124:8–10
   PubMed Web of Science ®Google Scholar
• Shen N, Wang J, Zhao M, et al. (2011). Anti-interleukin17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice. Inhal Toxicol 23:212–18
   PubMed Web of Science ®Google Scholar
• Tattersfield AE. (1990). Respiratory function in the elderly and the effects of beta blockade. Cardiovasc Drugs Ther 4:1229–32
   Google Scholar
• Heart Failure Society of America. (2006). The Heart Failure Society of America executive summary: the HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 12:10–38
   PubMed Web of Science ®Google Scholar
• Van Gestel YR, Hoeks SE, Sin DD, et al. (2009). Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD. Int J Chron Obstruct Pulmon Dis 4:177–83
   PubMedGoogle Scholar
• Verhein KC, Fryer AD, Jacoby DB. (2009). Neural control of airway inflammation. Curr Aller Asth Rep 9:484–90
   PubMed Web of Science ®Google Scholar
• Wang W, Xu M, Zhang YY, et al. (2009). Fenoterol, a β2-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4/CD14 complex and inflammatory cytokines production through β-arrestin-2 in THP-1 cell line. Acta Pharmacol Sin 30:1522–8
   PubMed Web of Science ®Google Scholar
• Yu-Tao Li, Bei He, Yu-Zhu Wang, et al. (2009). Effects of intra-tracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice. Resp Res 10:79–92
   PubMed Web of Science ®Google Scholar
• Zhong N, Wang C, Yao W, et al. (2007). Prevalence of COPDin China: a large, population-based survery. Am J Respir Crit Care Med 176:753–60
   PubMed Web of Science ®Google Scholar